The TGFβ-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1

Open Biology

Volumn 3, Issue JUN, 2013, Pages

  Sapkota, Gopal P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

MAP3K10; MAP3K4; MLK2; SMAD; TAK1; Transforming growth factor

Indexed keywords

MAP KINASE KINASE KINASE 7; MAP3K10 PROTEIN, HUMAN; MAP3K4 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENE TARGETING; GENETICS; HUMAN; METABOLISM; MOUSE; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; MAP3K10; MAP3K4; MLK2; SMAD; TAK1;

ANIMALS; CELL LINE; GENE KNOCK-IN TECHNIQUES; HUMANS; MAP KINASE KINASE KINASE 4; MAP KINASE KINASE KINASES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MAP3K10; MAP3K4; MLK2; SMAD; TAK1; TRANSFORMING GROWTH FACTOR;

EID: 84885648378     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.130067     Document Type: Article

References (46)

1. Shi Y, Massague J. 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700.
2. Zhang YE. 2009 Non-Smad pathways in TGF-β signaling. Cell Res. 19, 128-139. (doi:10.1038/cr.2008.328)
3. Derynck R, Akhurst RJ. 2007 Differentiation plasticity regulated by TGF-β family proteins in development and disease. Nat. Cell Biol. 9, 1000-1004. (doi:10.1038/ncb434)
4. Hawinkels LJ, Ten Dijke P. 2011 Exploring anti-TGFβ therapies in cancer and fibrosis. Growth Factors 29, 140-152. (doi:10.3109/08977194.2011. 595411)
5. Massague J. 2008 TGFβ in cancer. Cell 134, 215-230. (doi:10.1016/j.cell.2008.07.001)
6. Al-Salihi MA, Herhaus L, Sapkota GP. 2012 Regulation of the transforming growth factor β pathway by reversible ubiquitylation. Open Biol. 2, 120082. (doi:10.1098/rsob.120082)
7. Bruce DL, Macartney T, Yong W, Shou W, Sapkota GP. 2012 Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-β pathway. Cell Signal. 24, 1999-2006. (doi:10.1016/j.cellsig.2012.07.003)
8. Massague J. 2012 TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630. (doi:10.1038/nrm3434)
9. Bruce DL, Sapkota GP. 2012 Phosphatases in SMAD regulation. FEBS Lett. 586, 1897-1905. (doi:10.1016/j.febslet.2012.02.001)
10. Kim SI, Kwak JH, Na HJ, Kim JK, Ding Y, Choi ME. 2009 Transforming growth factor-β (TGF-β1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-β receptor kinase activity in mesangial cells. J. Biol. Chem. 284, 22 285-22 296. (doi:10.1074/jbc.M109. 007146)
11. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M. 2008 The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10, 1199-1207. (doi:10.1038/ncb1780)
12. Kim KY, Kim BC, Xu Z, Kim SJ. 2004 Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-βinduced apoptosis in hepatoma cells. J. Biol. Chem. 279, 29 478-29 484. (doi:10.1074/jbc.M313947200)
13. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace Jr AJ, Liebermann DA, Bottinger EP, Roberts AB. 2003 Transforming growth factor-βinduced apoptosis is mediated by SMAD-dependent expression of GADD45b through p38 activation. J. Biol. Chem. 278, 43 001-43 007. (doi:10.1074/jbc.M307869200)
14. Yu L, Hebert MC, Zhang YE. 2002 TGF-β receptor-activated p38 MAP kinase mediates SMADindependent TGF-β responses. EMBO J. 21, 3749-3759. (doi:10.1093/emboj/cdf366)
15. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. 2002 SMAD-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J. 21, 6473-6482.
16. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. 2002 p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115, 3193-3206.
17. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011.
18. Cuenda A, Rousseau S. 2007 p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773, 1358-1375. (doi:10.1016/j.bbamcr.2007.03.010)
19. Risco A, Cuenda A. 2012 New Insights into the p38g and p38d MAPK pathways. J. Signal Transduct. 2012, 520289. (doi:10.1155/2012/520289)
20. Brancho D et al. 2003 Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969-1978. (doi:10.1101/gad.1107303)
21. Beardmore VA et al. 2005 Generation and characterization of p38b (MAPK11) gene-targeted mice. Mol. Cell Biol. 25, 10 454-10 464. (doi:10.1128/MCB.25.23. 10454-10464.2005)
22. Thakur N, Sorrentino A, Heldin CH, Landstrom M. 2009 TGF-β uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells. Future Oncol. 5, 1-3. (doi:10.2217/14796694.5.1.1)
23. Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, Flavell RA, Davis RJ. 2011 TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev. 25, 2069-2078. (doi:10.1101/gad.17224711)
24. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. 2008 TRAF6 mediates SMAD-independent activation of JNK and p38 by TGF-β. Mol. Cell. 31, 918-924. (doi:10.1016/j.molcel.2008.09.002)
25. Walsh MC, Kim GK, Maurizio PL, Molnar EE, Choi Y. 2008 TRAF6 autoubiquitination-independent activation of the NFκB and MAPK pathways in response to IL-1 and RANKL. PLoS ONE 3, e4064. (doi:10.1371/journal.pone. 0004064)
26. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996 TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446. (doi:10.1038/383443a0)
27. Zhang L et al. 2003 A role for MEK kinase 1 in TGFβ/activin-induced epithelium movement and embryonic eyelid closure. EMBO J. 22, 4443-4454. (doi:10.1093/emboj/cdg440)
28. Sato S, Sanjo H, Tsujimura T, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Takeuchi O, Akira S. 2006 TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int. Immunol. 18, 1405-1411. (doi:10.1093/intimm/dxl082)
29. Shim JH et al. 2005 TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681. (doi:10.1101/gad.1360605)
30. Cheung PC, Campbell DG, Nebreda AR, Cohen P. 2003 Feedback control of the protein kinase TAK1 by SAPK2a/p38a. EMBO J. 22, 5793-5805. (doi:10.1093/emboj/ cdg552)
31. Shim JH, Greenblatt MB, Xie M, Schneider MD, Zou W, Zhai B, Gygi S, Glimcher LH. 2009 TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J. 28, 2028-2041. (doi:10.1038/emboj.2009.162)
32. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S. 2005 Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095. (doi:10.1038/ni1255)
33. Abell AN et al. 2005 Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol. Cell Biol. 25, 8948-8959. (doi:10.1128/MCB.25.20.8948-8959.2005)
34. Knockaert M, Sapkota G, Alarcon C, Massague J, Brivanlou AH. 2006 Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate SMAD1 to attenuate BMP signaling. Proc. Natl Acad. Sci. USA 103, 11 940-11 945. (doi:10.1073/pnas.0605133103)
35. Patil C, Zhu X, Rossa Jr C, Kim YJ, Kirkwood KL. 2004 p38 MAPK regulates IL-1b induced IL-6 expression through mRNA stability in osteoblasts. Immunol. Invest. 33, 213-233.
36. Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK. 2007 Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J. 26, 2890-2903. (doi:10.1038/sj.emboj.7601734)
37. Ananieva O et al. 2008 The kinases MSK1 and MSK2 act as negative regulators of toll-like receptor signaling. Nat. Immunol. 9, 1028-1036. (doi:10.1038/ni.1644)
38. Sinfield JK, Das A, O'Regan DJ, Ball SG, Porter KE, Turner NA. 2013 p38 MAPK a mediates cytokineinduced IL-6 and MMP-3 expression in human cardiac fibroblasts. Biochem. Biophys. Res. Commun. 430, 419-424. (doi:10.1016/j.bbrc. 2012.11.071)
39. Haddad JJ. 2001 VX-745. Vertex pharmaceuticals. Curr. Opin. Invest. Drugs 2, 1070-1076.
40. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massague J. 1996 A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623. (doi:10.1038/381620a0)
41. Zhang Y, Feng X, We R, Derynck R. 1996 Receptorassociated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172. (doi:10.1038/383168a0)
42. Cohen P. 2009 Targeting protein kinases for the development of anti-inflammatory drugs. Curr. Opin. Cell Biol. 21, 317-324. (doi:10.1016/j.ceb.2009.01.015)
43. van der Heide LP, van Dinther M, Moustakas A, ten Dijke P. 2011 TGFβ activates mitogen- and stressactivated protein kinase-1 (MSK1) to attenuate cell death. J. Biol. Chem. 286, 5003-5011. (doi:10.1074/jbc.M110.167379)
44. Vogt J, Traynor R, Sapkota GP. 2011 The specificities of small molecule inhibitors of the TGFβ and BMP pathways. Cell Signal. 23, 1831-1842. (doi:10.1016/j.cellsig.2011.06.019)
45. Al-Salihi MA, Herhaus L, Macartney T, Sapkota GP. 2012 USP11 augments TGFβ signalling by deubiquitylating ALK5. Open Biol. 2, 120063. (doi:10.1098/rsob.120063)
46. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. 2007 Balancing BMP signaling through integrated inputs into the SMAD1 linker. Mol. Cell. 25, 441-454. (doi:10.1016/j.molcel.2007.01.006)